Hofman-Bang C - Search Results

1

Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.

Braunschweig F, Linde C, Eriksson MJ, Hofman-Bang C, Rydén L. Braunschweig F, et al. Eur Heart J. 2002 Jan;23(1):59-69. doi: 10.1053/euhj.2001.2690. Eur Heart J. 2002. PMID: 11741363

2

[Mortality studies in heart failure. The role of ACE inhibitors becomes more important].

Hofman-Bang C, Rydén L, Ponikowski P. Hofman-Bang C, et al. Lakartidningen. 1991 Dec 18;88(51-52):4407-9. Lakartidningen. 1991. PMID: 1774980 Review. Swedish. No abstract available.

3

Acute cobalt exposure and oxygen radical scavengers in the rat myocardium.

Hatori N, Pehrsson SK, Clyne N, Hansson G, Hofman-Bang C, Marklund SL, Rydén L, Sjöqvist PO, Svensson L. Hatori N, et al. Biochim Biophys Acta. 1993 Jun 19;1181(3):257-60. doi: 10.1016/0925-4439(93)90029-z. Biochim Biophys Acta. 1993. PMID: 8391326

4

Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.

Hofman-Bang C, Rehnqvist N, Swedberg K, Wiklund I, Aström H. Hofman-Bang C, et al. J Card Fail. 1995 Mar;1(2):101-7. doi: 10.1016/1071-9164(95)90011-x. J Card Fail. 1995. PMID: 9420639 Clinical Trial.

5

[Angina pectoris is an expensive national disease. It requires a reasonable distribution of responsibility between outpatient and inpatient care].

Nilsson P, Hedblad B, Erhardt L, Hofman-Bang C, Rydén L. Nilsson P, et al. Lakartidningen. 1998 May 20;95(21):2430-2, 2435-6. Lakartidningen. 1998. PMID: 9640911 Review. Swedish. No abstract available.

6

Multifactorial evaluation of a program for lifestyle behavior change in rehabilitation and secondary prevention of coronary artery disease.

Lisspers J, Hofman-Bang C, Nordlander R, Rydèn L, Sundin O, Ohman A, Nygren A. Lisspers J, et al. Scand Cardiovasc J. 1999;33(1):9-16. doi: 10.1080/14017439950141975. Scand Cardiovasc J. 1999. PMID: 10093853 Free article.

7

Behavioral effects of a comprehensive, multifactorial program for lifestyle change after percutaneous transluminal coronary angioplasty: a prospective, randomized controlled study.

Lisspers J, Sundin O, Hofman-Bang C, Nordlander R, Nygren A, Rydén L, Ohman A. Lisspers J, et al. J Psychosom Res. 1999 Feb;46(2):143-54. doi: 10.1016/s0022-3999(98)00074-9. J Psychosom Res. 1999. PMID: 10098823 Clinical Trial.

8

Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme.

Hofman-Bang C, Lisspers J, Nordlander R, Nygren A, Sundin O, Ohman A, Rydén L. Hofman-Bang C, et al. Eur Heart J. 1999 Oct;20(20):1465-74. doi: 10.1053/euhj.1999.1544. Eur Heart J. 1999. PMID: 10493845 Clinical Trial.

9

[Few patients with coronary diseases are receiving lipid-lowering therapy].

Stagmo M, Hofman-Bang C, Erhardt L, Rydén L. Stagmo M, et al. Lakartidningen. 2002 Apr 18;99(16):1798-9, 1802-3. Lakartidningen. 2002. PMID: 12043479 Swedish. No abstract available.

10

Comparing multifactorial lifestyle interventions and stress management in coronary risk reduction.

Sundin O, Lisspers J, Hofman-Bang C, Nygren A, Rydén L, Ohman A. Sundin O, et al. Int J Behav Med. 2003;10(3):191-204. doi: 10.1207/s15327558ijbm1003_01. Int J Behav Med. 2003. PMID: 14525716 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters